Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus

Québec, Quebec G1J 1Z4

4 studies enrolling now · 5 studies all time

What they study most

Advanced Malignant Tumors, Advanced or Metastatic Solid Tumors, Brain Neoplasms, Cancer of the Prostate, Carcinoma, Non-Small-Cell Lung, Differentiated Thyroid Cancer, Endometrial Neoplasms, Glioma, HGG, Head and Neck Neoplasms, High Grade Glioma, Hormone Sensitive Prostate Cancer

Studies at this site

• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors — Recruiting now
• A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors — Recruiting now
• A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer — Recruiting now
• A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 — Running, not enrolling